BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 7, 2019
View Archived Issues
Identification of PDE10A inhibitors with potential application in schizophrenia
Read More
Phase III data demonstrates equivalence between SB8 and bevacizumab in terms of best ORR
Read More
Shanghai Fochon Pharmaceutical, Fochon Pharmaceuticals patent TRK inhibitors
Read More
Development of novel sclerostin-resistant mouse model of T1D
Read More
Symphogen presents early clinical data for Sym-015 in advanced solid tumors
Read More
Results presented from phase III SANET-ep study of surufatinib
Read More
First-in-human study of apramycin
Read More
GlaxoSmithKline initiates phase I study of GSK-2904545A vaccine candidate
Read More
CAR-iNKT cells safe and active in neuroblastoma patients
Read More
Preclinical results for IKS-01, a next-generation ADC with antitumor activity
Read More
Escalier Biosciences describes new RORgammaT modulators
Read More
Mavupharma presents E-NPP1 inhibitors
Read More
Peptide Logic awarded NIH HEAL initiative grant
Read More
New GBP1 and/or GBP1/PIM1 interaction inhibitors discovered at Stanford University
Read More
Arbutus Biopharma patents HBsAg secretion inhibitors
Read More
Keeping score by DRUP, not in dribs and drabs
Read More
Shire Human Genetic Therapies presents new kallikrein B inhibitors
Read More
Main function of Parkinson's gene is in inflammation
Read More
FDA approves Aklief cream for topical treatment of acne
Read More
GSK begins first-in-human study of rabies vaccine GSK-3903133A
Read More
Positive phase II data presented for lurbinectedin in malignant pleural mesothelioma
Read More
ReveraGen presents 18-month data on vamorolone in Duchenne muscular dystrophy
Read More
Kodiak begins phase II study of KSI-301 for wet AMD
Read More